Article Details
Retrieved on: 2021-06-22 08:46:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The agreement itself will see KBI Biopharma conduct drug substance manufacturing, as well as process characterization and validation work, for the ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here